These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12230086)

  • 21. Treatment of special populations with the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():46-52. PubMed ID: 9766620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Olanzapine and clozapine: comparative effects on motor function in hallucinating PD patients.
    Goetz CG; Blasucci LM; Leurgans S; Pappert EJ
    Neurology; 2000 Sep; 55(6):789-94. PubMed ID: 10993997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Atypical antipsychotics].
    Naber D
    Nervenarzt; 2000 May; 71(5):327-8. PubMed ID: 10846707
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of three antipsychotics in the emergency psychiatric setting.
    Raja M; Azzoni A
    Hum Psychopharmacol; 2003 Aug; 18(6):447-52. PubMed ID: 12923822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quetiapine as an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease.
    Menza MM; Palermo B; Mark M
    Ann Clin Psychiatry; 1999 Sep; 11(3):141-4. PubMed ID: 10482124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics.
    Tauscher J; Hussain T; Agid O; Verhoeff NP; Wilson AA; Houle S; Remington G; Zipursky RB; Kapur S
    Am J Psychiatry; 2004 Sep; 161(9):1620-5. PubMed ID: 15337652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
    Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From conventional to atypical antipsychotics and back: dynamic processes in the diffusion of new medications.
    Leslie DL; Rosenheck RA
    Am J Psychiatry; 2002 Sep; 159(9):1534-40. PubMed ID: 12202274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological approaches to the management of schizophrenia.
    Lambert TJ; Castle DJ
    Med J Aust; 2003 May; 178(S9):S57-61. PubMed ID: 12720524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia.
    Keck PE; Strakowski SM; McElroy SL
    J Clin Psychiatry; 2000; 61 Suppl 3():4-9. PubMed ID: 10724127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of the newer atypical antipsychotics: a review of the pharmacoeconomic research evidence.
    Revicki DA
    Curr Opin Investig Drugs; 2001 Jan; 2(1):110-7. PubMed ID: 11527002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tardive dyskinesia in older patients.
    Jeste DV
    J Clin Psychiatry; 2000; 61 Suppl 4():27-32. PubMed ID: 10739328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similarities and differences among antipsychotics.
    Tamminga CA
    J Clin Psychiatry; 2003; 64 Suppl 17():7-10. PubMed ID: 14680420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine and risperidone treatment of psychosis in Parkinson's disease.
    Ellis T; Cudkowicz ME; Sexton PM; Growdon JH
    J Neuropsychiatry Clin Neurosci; 2000; 12(3):364-9. PubMed ID: 10956570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic treatment of schizophrenia.
    Kane JM
    Biol Psychiatry; 1999 Nov; 46(10):1396-408. PubMed ID: 10578454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of quetiapine in elderly patients.
    Tariot PN; Ismail MS
    J Clin Psychiatry; 2002; 63 Suppl 13():21-6. PubMed ID: 12562143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rater-blinded, prospective comparison: quetiapine versus clozapine for Parkinson's disease psychosis.
    Merims D; Balas M; Peretz C; Shabtai H; Giladi N
    Clin Neuropharmacol; 2006; 29(6):331-7. PubMed ID: 17095896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug metabolism and atypical antipsychotics.
    Prior TI; Chue PS; Tibbo P; Baker GB
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):301-9. PubMed ID: 10422890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.